BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 3096560)

  • 1. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
    Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.
    Porter CW; McManis J; Casero RA; Bergeron RJ
    Cancer Res; 1987 Jun; 47(11):2821-5. PubMed ID: 3567905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.
    Porter CW; Cavanaugh PF; Stolowich N; Ganis B; Kelly E; Bergeron RJ
    Cancer Res; 1985 May; 45(5):2050-7. PubMed ID: 3921235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
    Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
    Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.
    Pera PJ; Kramer DL; Sufrin JR; Porter CW
    Cancer Res; 1986 Mar; 46(3):1148-54. PubMed ID: 3080234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of N1- and N8-aziridinyl analogues of spermidine.
    Yuan ZM; Egorin MJ; Rosen DM; Simon MA; Callery PS
    Cancer Res; 1994 Feb; 54(3):742-8. PubMed ID: 8306336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
    Ghoda L; Basu HS; Porter CW; Marton LJ; Coffino P
    Mol Pharmacol; 1992 Aug; 42(2):302-6. PubMed ID: 1513327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells.
    Libby PR; Henderson M; Bergeron RJ; Porter CW
    Cancer Res; 1989 Nov; 49(22):6226-31. PubMed ID: 2804970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ornithine decarboxylase activity and cell growth by diamines: a comparison between the effects of two homologs, 1,3-diaminopropane and 1,4-diaminobutane (putrescine).
    Linden M; Oredsson SM; Anehus S; Heby O
    J Cell Biochem; 1985; 29(2):105-13. PubMed ID: 3934184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells.
    Cavanaugh PF; Pavelic ZP; Porter CW
    Cancer Res; 1984 Sep; 44(9):3856-61. PubMed ID: 6430555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of L1210 cells resistant to alpha-difluoromethylornithine.
    Pegg AE; Secrist JA; Madhubala R
    Cancer Res; 1988 May; 48(10):2678-82. PubMed ID: 3129184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with alpha-difluoromethylornithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells.
    Casero RA; Bergeron RJ; Porter CW
    J Cell Physiol; 1984 Dec; 121(3):476-82. PubMed ID: 6438117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
    Claverie N; Mamont PS
    Cancer Res; 1989 Aug; 49(16):4466-71. PubMed ID: 2501026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
    Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
    J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine.
    Porter CW; Berger FG; Pegg AE; Ganis B; Bergeron RJ
    Biochem J; 1987 Mar; 242(2):433-40. PubMed ID: 3036091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
    Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
    Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of polyamines in the proliferation of cultured retinal pigment epithelial cells.
    Yanagihara N; Moriwaki M; Shiraki K; Miki T; Otani S
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):1975-83. PubMed ID: 8814137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
    Pfaller MA; Riley J; Gerarden T
    J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
    Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J
    J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.